FindTrial
Sign In

Construction and application of integrated digital intelligence drug management model for elderly patients with chronic diseases from the perspective of MDT

Construction and application of integrated digital intelligence drug management model for elderly patients with chronic diseases from the perspective of MDT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123058
Enrollment
Unknown
Registered
2026-04-21
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic diseases in the elderly such as hypertension/heart failure/diabetes

Interventions

interventional group:Digital intelligent drug management model
control group:conventional care

Sponsors

Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years; 2. With >= 2 chronic diseases (such as hypertension, diabetes, coronary heart disease, etc.); 3. More than 5 kinds of oral drugs are used; 4. Have the ability to use basic digital devices (such as smart phones); 5. Volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment, end-stage disease or life expectancy < 1 year; 2. Refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
medication compliance;medication literacy;Medication deviation;—

Secondary

MeasureTime frame
Readmission rate;Medical costs;—

Countries

China

Contacts

Public ContactZhao xiaoyan

Affiliated Hospital of Jiangsu University

214535124@qq.com+86 159 5286 1255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026